Evidence for allelic association of the dopamine β-hydroxylase gene (DBH) with susceptibility to typical migraine

Neurogenetics

Volumn 3, Issue 1, 2000, Pages 35-40

  Lea, R A ^a   Dohy, A ^a   Jordan, K ^a   Quinlan, S ^a   Brimage, P J ^b   Griffiths, L R ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

DBH; DRD2; Linkage; Migraine; SERT

Indexed keywords

CACNA1A PROTEIN, HUMAN; CALCIUM CHANNEL; CARRIER PROTEIN; DOPAMINE BETA MONOOXYGENASE; DOPAMINE RECEPTOR; MEMBRANE PROTEIN; NERVE PROTEIN; SEROTONIN TRANSPORTER; SLC6A4 PROTEIN, HUMAN;

ALLELE; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; FAMILY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; MIGRAINE; PREVALENCE; REFERENCE VALUE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ALLELES; CALCIUM CHANNELS; CARRIER PROTEINS; CASE-CONTROL STUDIES; DOPAMINE BETA-HYDROXYLASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FAMILY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIGRAINE DISORDERS; NERVE TISSUE PROTEINS; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREVALENCE; RECEPTORS, DOPAMINE; REFERENCE VALUES; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 0034279414     PISSN: 13646745     EISSN: None     Source Type: Journal    
DOI: 10.007/s100480000097     Document Type: Article

References (33)

1. Kurtzke JF (1982) The current neurologic burden of illness and injury in the United States. Neurology 32:1207-1214
2. Stewart WF, Lipton RB, Celentano DD, et al (1992) Prevalence of migraine headache in the United States. JAMA 267:64-69
3. Launer LJ, Terwindt GM, Ferrari MD (1999) The prevalence and characteristics of migraine in a population-based cohort - The GEM Study. Neurology 53:537-542
4. Honkasalo ML, Kaprio J, Winter T, et al (1995) Migraine and concomitant symptoms among 8167 adult twin pairs. Headache 35:70-78
5. Larsson B, Bille B, Pedersen NL (1995) Genetic influences in headaches: a Swedish twin study. Headache 35:513-519
6. Russell MB, Olesen J (1992) The genetics of migraine without aura and migraine with aura. Cephalalgia 13:245-248
7. Headache Classification Committee of the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8 [Suppl 7]:19-28
8. Mochi M, Sangiorgi S, Cortelli P, et al (1993) Testing models for genetic determination in migraine. Cephalalgia 13:389-394
9. Bille B (1997) A 40 year follow-up of school children with migraine. Cephalalgia 17:488-491
10. Russell MB, Rasmussen BK, Thorvaldsen P, Olesen J (1995) Prevalence and sex-ratio of the subtypes of migraine. Int J Epidemiol 24:612-618
11. Blau JN (1995) Migraine with and without aura are not different entities. Cephalalgia 15:186-189
12. Ogilvie AD, Russell MB, Dhall P, et al (1998) Altered allelic distributions of the serotonin transporter gene in migraine without aura and migraine with aura. Cephalalgia 18:23-26
13. Peroutka SJ, Wilhoit T, Jones K (1997) Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles. Neurology 49:201-206
14. Wilson AF, Elston RC, Siervogel RM, Tran LD (1998) Linkage of a gene regulating dopamine-beta-hydroxylase activity and the ABO blood group locus. Am J Hum Genet 42:160-166
15. Anthony M (1981) Biochemical indices of sympathetic activity in migraine. Cephalalgia 1:83-89
16. Gotoh F, Kanda T, Sakai F, Yamamoto M, Takeoka T (1976) Serum dopamine-beta-hydroxylase activity in migraine. Arch Neurol 33:656-657
17. Nahmias J, Burley M, Povey S, et al (1992) A 19 bp deletion polymorphism adjacent to a dinucleotide repeat polymorphism at the human dopamine β-hydroylase locus. Hum Mol Genet 1:286
18. Kong A, Cox NJ (1997) Allele-sharing models: LOD scores and accurate linkage tests. Am J Hum Genet 61:1179-1188
19. Davis S, Schroeder M, Goldin LR, Weeks DE (1996) Non-parametric simulation-based statistics for detecting linkage in general pedigrees. Am J Hum Genet 58:867-880
20. Nyholt DR, Lea RA, Goadsby PJ, et al (1998) Familial typical migraine - linkage to chromosome 19p13 and evidence for genetic heterogeneity. Neurology 50:1428-1432
21. Clayton D (1997) TRANSMIT http://www.mrc-bsu.cam.ac.uk/pub/methodology/genetics/
22. Spielman RS, McGinnis RE, Ewens WJ (1993) Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506-516
23. Sham PC, Curtis D (1995) Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 59:97-105
24. Raymond M, Roussel F (1995) GENEPOP (version 1.2): population genetics software for exact tests and ecumenicism. J Hered 86:248-249
25. 2+ channel gene CACNL1A4. Cell 87:543-552
26. Battistini S, Stenirri S, Piatti M, et al (1999) A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia. Neurology 13:38-43
27. Codignola A, Tarroni P, Clementi F, et al (1993) Calcium channel subtypes controlling serotonin release from human cell lung carcinoma cell lines. J Biol Chem 268:26240-26247
28. Risch N (1990) Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet 46:229-241
29. Risch N (1990) Linkage strategies for genetically complex traits. III. The effect of marker polymorphism on analysis of affected relative pairs. Am J Hum Genet 46:242-253
30. Russell MB, Iselius L, Olesen J (1996) Migraine without aura and migraine with aura are inherited disorders. Cephalalgia 16:305-309
31. Del Zompo M, Cherchi A, Palmas MA, et al (1998) Association between dopamine receptor genes and migraine without aura in a Sardinian sample. Neurology 51:781-786
32. Ogilvie AD, Battersby S, Bubb VJ, et al (1996) A polymorphism of the serotonin transporter gene is associated with susceptibility to major affective disorder. Lancet 347:731-733
33. Monari L, Mochi M, Valentino M.L, et al (1997) Searching for migraine genes: exclusion of 290 cM out of the whole human genome. Ital J Neurol Sci 18:277-282